RUNX Genes in Development and Cancer: Regulation of Viral Gene Expression and the Discovery of RUNX Family Genes

Advances in Cancer Research

Volumn 99, Issue , 2008, Pages 33-76

  Ito, Yoshiaki ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; CORE BINDING FACTOR; DNA; DNA BINDING PROTEIN; POLYOMAVIRUS ENHANCER BINDING PROTEIN 2; POLYOMAVIRUS ENHANCER BINDING PROTEIN 3; RUNT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

BIOLOGICAL MODEL; BONE DEVELOPMENT; CANCER GENETICS; CANCER INHIBITION; CELL DIFFERENTIATION; CELL ISOLATION; CHROMOSOME TRANSLOCATION; DNA BINDING MOTIF; DNA REPLICATION; DROSOPHILA; EMBRYO SEGMENTATION; EMBRYONAL CARCINOMA; FUSION GENE; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC PURITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; KNOCKOUT GENE; LEUKEMIA; MOLECULAR CLONING; MULTIGENE FAMILY; MYELOID LEUKEMIA; NERVE CELL; NERVE CONDUCTION; NONHUMAN; PHENOTYPE; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; REVIEW; STOMACH CANCER; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; TUMOR VIRUS; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS MUTANT;

ANIMALS; CORE BINDING FACTOR ALPHA SUBUNITS; EMBRYONAL CARCINOMA STEM CELLS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HUMANS; LEUKEMIA; MUTATION; ONCOGENES; POLYOMAVIRUS; RABBITS;

EID: 36348962321     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(07)99002-8     Document Type: Review

References (142)

1. Artzt K., Dubois P., Bennett D., Condamine H., Babinet C., and Jacob F. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc. Natl. Acad. Sci. USA 70 (1973) 2988-2992
2. Asano M., Murakami Y., Furukawa K., Yamaguchi-Iwai Y., Satake M., and Ito Y. A polyomavirus enhancer-binding protein, PEBP5, responsive to 12-O-tetradecanoylphorbol-13-acetate but distinct from AP-1. J. Virol. 64 (1990) 5927-5938
3. Avraham K.B., Levanon D., Negreanu V., Bernstein Y., Groner Y., Copeland N.G., and Jenkins N.A. Mapping of the mouse homolog of the human runt domain gene, AML2, to the distal region of mouse chromosome 4. Genomics 25 (1995) 603-605
4. Bae S.C., Yamaguchi-Iwai Y., Ogawa E., Maruyama M., Inuzuka M., Kagoshima H., Shigesada K., Satake M., and Ito Y. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8 (1993) 809-814
5. Bae S.C., Ogawa E., Maruyama M., Oka H., Satake M., Shigesada K., Jenkins N.A., Gilbert D.J., Copeland N.G., and Ito Y. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14 (1994) 3242-3252
6. Bae S.C., Takahashi E., Zhang Y.W., Ogawa E., Shigesada K., Namba Y., Satake M., and Ito Y. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 159 (1995) 245-248
7. Banerji J., Rusconi S., and Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27 (1981) 299-308
8. Bangsow C., Rubins N., Glusman G., Bernstein Y., Negreanu V., Goldenberg D., Lotem J., Ben-Asher E., Lancet D., Levanon D., and Groner Y. The RUNX3 gene-sequence, structure and regulated expression. Gene 279 (2001) 221-232
9. Blyth K., Cameron E.R., and Neil J.C. The RUNX genes: Gain or loss of function in cancer. Nat. Rev. Cancer 5 (2005) 376-387
10. Boccara M., and Kelly F. Expression of polyoma virus in heterokaryons between embryonal carcinoma cells and differentiated cells. Virology 90 (1978) 147-150
11. Bohnlein E., and Gruss P. Interaction of distinct nuclear proteins with sequences controlling the expression of polyomavirus early genes. Mol. Cell. Biol. 6 (1986) 1401-1411
12. Borrelli E., Hen R., and Chambon P. Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription. Nature 312 (1984) 608-612
13. Bos T.J., Bohmann D., Tsuchie H., Tjian R., and Vogt P.K. v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell 52 (1988) 705-712
14. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., and Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA 101 (2004) 16016-16021
15. Burns C.E., DeBlasio T., Zhou Y., Zhang J., Zon L., and Nimer S.D. Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators. Exp. Hematol. 30 (2002) 1381-1389
16. Burns C.E., Traver D., Mayhall E., Shepard J.L., and Zon L.I. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 19 (2005) 2331-2342
17. Calabi F., Rhodes M., Williamson P., and Boyd Y. Identification and chromosomal mapping of a third mouse runt-like locus. Genomics 26 (1995) 607-610
18. Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., and Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87 (1996) 687-696
19. Chen L.F., Ito K., Murakami Y., and Ito Y. The capacity of polyomavirus enhancer binding protein 2alphaB (AML1/Cbfa2) to stimulate polyomavirus DNA replication is related to its affinity for the nuclear matrix. Mol. Cell. Biol. 18 (1998) 4165-4176
20. Coffman J.A., Kirchhamer C.V., Harrington M.G., and Davidson E.H. SpRunt-1, a new member of the runt domain family of transcription factors, is a positive regulator of the aboral ectoderm-specific CyIIIA gene in sea urchin embryos. Dev. Biol. 174 (1996) 43-54
21. Crosier P.S., Kalev-Zylinska M.L., Hall C.J., Flores M.V., Horsfield J.A., and Crosier K.E. Pathways in blood and vessel development revealed through zebrafish genetics. Int. J. Dev. Biol. 46 (2002) 493-502
22. Curran T., Peters G., Van Beveren C., Teich N.M., and Verma I.M. FBJ murine osteosarcoma virus: Identification and molecular cloning of biologically active proviral DNA. J. Virol. 44 (1982) 674-682
23. Daga A., Karlovich C.A., Dumstrei K., and Banerjee U. Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes Dev. 10 (1996) 1194-1205
24. de Villiers J., and Schaffner W. A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs. Nucleic Acids Res. 9 (1981) 6251-6264
25. de Villiers J., Olson L., Tyndall C., and Schaffner W. Transcriptional 'enhancers' from SV40 and polyoma virus show a cell type preference. Nucleic Acids Res. 10 (1982) 7965-7976
26. de Villiers J., Schaffner W., Tyndall C., Lupton S., and Kamen R. Polyoma virus DNA replication requires an enhancer. Nature 312 (1984) 242-246
27. Delli Bovi P., De Simone V., Giordano R., and Amati P. Polyomavirus growth and persistence in Friend erythroleukemic cells. J. Virol. 49 (1984) 566-571
28. Dilworth S.M. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat. Rev. Cancer 2 (2002) 951-956
29. Fainaru O., Woolf E., Lotem J., Yarmus M., Brenner O., Goldenberg D., Negreanu V., Bernstein Y., Levanon D., Jung S., and Groner Y. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23 (2004) 969-979
30. Fujimura F.K. Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs. Nucleic Acids Res. 14 (1986) 2845-2861
31. Fujimura F.K., and Linney E. Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells. Proc. Natl. Acad. Sci. USA 79 (1982) 1479-1483
32. Fujimura F.K., Deininger P.L., Friedmann T., and Linney E. Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell 23 (1981) 809-814
33. Fukamachi H., Ito K., and Ito Y. Runx3-/-gastric epithelial cells differentiate into intestinal type cells. Biochem. Biophys. Res. Commun. 321 (2004) 58-64
34. Furukawa K., Yamaguchi Y., Ogawa E., Shigesada K., Satake M., and Ito Y. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ. 1 (1990) 135-147
35. Georges E., Vasseur M., and Blangy D. Polyoma virus mutants as probes of variety among mouse embryonal carcinoma cell lines. Differentiation 22 (1982) 62-65
36. Golling G., Li L., Pepling M., Stebbins M., and Gergen J.P. Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt. Mol. Cell. Biol. 16 (1996) 932-942
37. Growney J.D., Shigematsu H., Li Z., Lee B.H., Adelsperger J., Rowan R., Curley D.P., Kutok J.L., Akashi K., Williams I.R., Speck N.A., and Gilliland D.G. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106 (2005) 494-504
38. Hen R., Borrelli E., Fromental C., Sassone-Corsi P., and Chambon P. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products. Nature 321 (1986) 249-251
39. Herbomel P., Bourachot B., and Yaniv M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39 (1984) 653-662
40. Ichikawa M., Asai T., Saito T., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., and Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10 (2004) 299-304
41. Imagawa M., Chiu R., and Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 51 (1987) 251-260
42. Imai Y., Kurokawa M., Tanaka K., Friedman A.D., Ogawa S., Mitani K., Yazaki Y., and Hirai H. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. Biochem. Biophys. Res. Commun. 252 (1998) 582-589
43. Inoue K., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., Iseda T., Kawaguchi S., Ogawa M., Bae S.C., Yamashita N., Itohara S., et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5 (2002) 946-954
44. Ito Y. Oncogenic potential of the RUNX gene family: 'Overview.'. Oncogene 23 (2004) 4198-4208
45. Ito Y., and Bae S.C. "The RUNX Gene Family.". Oncogene Rev. 23 24 (2004) 4193-4352
46. Jacob F. Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 33 (1977) 3-32
47. Jaenisch R., Harbers K., Jahner D., Stewart C., and Stuhlmann H. DNA methylation, retroviruses, and embryogenesis. J. Cell. Biochem. 20 (1982) 331-336
48. Kagoshima H., Shigesada K., Satake M., Ito Y., Miyoshi H., Ohki M., Pepling M., and Gergen P. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9 (1993) 338-341
49. Kagoshima H., Shigesada K., and Kohara Y. RUNX regulates stem cell proliferation and differentiation: Insights from studies of C. elegans. J. Cell. Biochem. 100 (2007) 1119-1130
50. Kamachi Y., Ogawa E., Asano M., Ishida S., Murakami Y., Satake M., Ito Y., and Shigesada K. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64 (1990) 4808-4819
51. Kania M.A., Bonner A.S., Duffy J.B., and Gergen J.P. The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev. 4 (1990) 1701-1713
52. Kanno T., Kanno Y., Chen L.F., Ogawa E., Kim W.Y., and Ito Y. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol. Cell. Biol. 18 (1998) 2444-2454
53. Kataoka H., Ochi M., Enomoto K., and Yamaguchi A. Cloning and embryonic expression patterns of the zebrafish Runt domain genes, runxa and runxb. Mech. Dev. 98 (2000) 139-143
54. Katinka M., Yaniv M., Vasseur M., and Blangy D. Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region. Cell 20 (1980) 393-399
55. Katinka M., Vasseur M., Montreau N., Yaniv M., and Blangy D. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells. Nature 290 (1981) 720-722
56. Kim W.J., Kim E.J., Jeong P., Quan C., Kim J., Li Q.L., Yang J.O., Ito Y., and Bae S.C. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res. 65 (2005) 9347-9354
57. Kim W.Y., Sieweke M., Ogawa E., Wee H.J., Englmeier U., Graf T., and Ito Y. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18 (1999) 1609-1620
58. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
59. Kovesdi I., Satake M., Furukawa K., Reichel R., Ito Y., and Nevins J.R. A factor discriminating between the wild-type and a mutant polyomavirus enhancer. Nature 328 (1987) 87-89
60. Kryszke M.H., Piette J., and Yaniv M. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature 328 (1987) 254-256
61. Lebestky T., Chang T., Hartenstein V., and Banerjee U. Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science 288 (2000) 146-149
62. Lee W., Mitchell P., and Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49 (1987) 741-752
63. Lehman J.M., Speers W.C., Swartzendruber D.E., and Pierce G.B. Neoplastic differentiation: Characteristics of cell lines derived from a murine teratocarcinoma. J. Cell. Physiol. 84 (1974) 13-27
64. Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., and Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23 (1994) 425-432
65. Levanon D., Goldstein R.E., Bernstein Y., Tang H., Goldenberg D., Stifani S., Paroush Z., and Groner Y. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA 95 (1998) 11590-11595
66. Levanon D., Glusman G., Bangsow T., Ben-Asher E., Male D.A., Avidan N., Bangsow C., Hattori M., Taylor T.D., Taudien S., Blechschmidt K., Shimizu N., et al. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene 262 (2001) 23-33
67. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., Bernstein Y., Goldenberg D., Xiao C., Fliegauf M., Kremer E., Otto F., et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21 (2002) 3454-3463
68. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 (2002) 113-124
69. Lim F., Kraut N., Framptom J., and Graf T. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism. EMBO J. 11 (1992) 643-652
70. Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., and Collins F.S. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261 (1993) 1041-1044
71. Liu Y., Shin S., Zeng X., Zhan M., Gonzalez R., Mueller F.J., Schwartz C.M., Xue H., Li H., Baker S.C., Chudin E., Barker D.L., et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev. Biol. 6 (2006) 20
72. Log T., Chang K.S., and Hsu Y.C. Carcinomas induced by cell lines cultivated from normal mouse placentas. Int. J. Cancer 27 (1981) 365-372
73. Maione R., Passananti C., De Simone V., Delli-Bovi P., Augusti-Tocco G., and Amati P. Selection of mouse neuroblastoma cell-specific polyoma virus mutants with stage differentiative advantages of replication. EMBO J. 4 (1985) 3215-3221
74. Maki Y., Bos T.J., Davis C., Starbuck M., and Vogt P.K. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl. Acad. Sci. USA 84 (1987) 2848-2852
75. Martin G.R. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia. Cell 5 (1975) 229-243
76. Martin M.E., Piette J., Yaniv M., Tang W.J., and Folk W.R. Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc. Natl. Acad. Sci. USA 85 (1988) 5839-5843
77. Mintz B., and Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72 (1975) 3585-3589
78. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., and Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88 (1991) 10431-10434
79. Miyoshi H., Ohira M., Shimizu K., Mitani K., Hirai H., Imai T., Yokoyama K., Soeda E., and Ohki M. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 23 (1995) 2762-2769
80. Moreau P., Hen R., Wasylyk B., Everett R., Gaub M.P., and Chambon P. The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res. 9 (1981) 6047-6068
81. Mueller C.R., Mes-Masson A.M., Bouvier M., and Hassell J.A. Location of sequences in polyomavirus DNA that are required for early gene expression in vivo and in vitro. Mol. Cell. Biol. 4 (1984) 2594-2609
82. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89 (1997) 773-779
83. Murakami Y., Asano M., Satake M., and Ito Y. A tumor promoting phorbol ester, TPA, enhances polyomavirus DNA replication by activating the function of the viral enhancer. Oncogene 5 (1990) 5-13
84. Nam S., Jin Y.H., Li Q.L., Lee K.Y., Jeong G.B., Ito Y., Lee J., and Bae S.C. Expression pattern, regulation, and biological role of runt domain transcription factor, run, in Caenorhabditis elegans. Mol. Cell. Biol. 22 (2002) 547-554
85. Nicolas J.F., Avner P., Gaillard J., Guenet J.L., Jakob H., and Jacob F. Cell lines derived from teratocarcinomas. Cancer Res. 36 (1976) 4224-4231
86. Niki M., Okada H., Takano H., Kuno J., Tani K., Hibino H., Asano S., Ito Y., Satake M., and Noda T. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl. Acad. Sci. USA 94 (1997) 5697-5702
87. North T., Gu T.L., Stacy T., Wang Q., Howard L., Binder M., Marin-Padilla M., and Speck N.A. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126 (1999) 2563-2575
88. Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y., and Shigesada K. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194 (1993) 314-331
89. Ogawa E., Maruyama M., Kagoshima H., Inuzuka M., Lu J., Satake M., Shigesada K., and Ito Y. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90 (1993) 6859-6863
90. Okada H., Watanabe T., Niki M., Takano H., Chiba N., Yanai N., Tani K., Hibino H., Asano S., Mucenski M.L., Ito Y., Noda T., et al. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene 17 (1998) 2287-2293
91. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
92. Osato M. Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia. Oncogene 23 (2004) 4284-4296
93. Ostapchuk P., Diffley J.F., Bruder J.T., Stillman B., Levine A.J., and Hearing P. Interaction of a nuclear factor with the polyomavirus enhancer region. Proc. Natl. Acad. Sci. USA 83 (1986) 8550-8554
94. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., and Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
95. Papaioannou V.E., McBurney M.W., Gardner R.L., and Evans M.J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258 (1975) 70-73
96. Paroush Z., Finley Jr. R.L., Kidd T., Wainwright S.M., Ingham P.W., Brent R., and Ish-Horowicz D. Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell 79 (1994) 805-815
97. Pierce Jr. G.B., Dixon Jr. F.J., and Verney E.L. Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies. Lab. Invest. 9 (1960) 583-602
98. Piette J., and Yaniv M. Molecular analysis of the interaction between an enhancer binding factor and its DNA target. Nucleic Acids Res. 14 (1986) 9595-9611
99. Piette J., and Yaniv M. Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J. 6 (1987) 1331-1337
100. Puig-Kroger A., and Corbi A. RUNX3: A new player in myeloid gene expression and immune response. J. Cell. Biochem. 98 (2006) 744-756
101. Putz G., Rosner A., Nuesslein I., Schmitz N., and Buchholz F. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 25 (2006) 929-939
102. Rennert J., Coffman J.A., Mushegian A.R., and Robertson A.J. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol. Biol. 3 (2003) 4
103. Satake M., Ibaraki T., and Ito Y. Modulation of polyomavirus enhancer binding proteins by Ha-ras oncogene. Oncogene 3 (1988) 69-78
104. Satake M., Ibaraki T., Yamaguchi Y., and Ito Y. Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J. Virol. 63 (1989) 3669-3677
105. Satake M., Inuzuka M., Shigesada K., Oikawa T., and Ito Y. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells. Jpn. J. Cancer Res. 83 (1992) 714-722
106. Sekikawa K., and Levine A.J. Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 78 (1981) 1100-1104
107. Song W.J., Sullivan M.G., Legare R.D., Hutchings S., Tan X., Kufrin D., Ratajczak J., Resende I.C., Haworth C., Hock R., Loh M., Felix C., et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23 (1999) 166-175
108. Speck N.A., and Baltimore D. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7 (1987) 1101-1110
109. Speck N.A., and Gilliland D.G. Core-binding factors in haematopoiesis and leukaemia. Nat. Rev. Cancer 2 (2002) 502-513
110. Speck N.A., Renjifo B., Golemis E., Fredrickson T.N., Hartley J.W., and Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4 (1990) 233-242
111. Speck N.A., Renjifo B., and Hopkins N. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64 (1990) 543-550
112. Stevens L.C., and Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. USA 40 (1954) 1080-1087
113. Stewart M., Terry A., Hu M., O'Hara M., Blyth K., Baxter E., Cameron E., Onions D.E., and Neil J.C. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): Evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94 (1997) 8646-8651
114. Stewart S.E., Eddy B.E., Irwin M., and Lee S. Development of resistance in mice to tumour induction by S E polyoma virus. Nature 186 (1960) 615-617
115. Strickland S., and Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15 (1978) 393-403
116. Swartzendruber D.E., and Lehman J.M. Neoplastic differentiation: Interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro. J. Cell. Physiol. 85 (1975) 179-187
117. Tanaka K., Chowdhury K., Chang K.S., Israel M., and Ito Y. Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells. EMBO J. 1 (1982) 1521-1527
118. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., and Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111 (2002) 621-633
119. Teich N.M., Weiss R.A., Martin G.R., and Lowy D.R. Virus infection of murine teratocarcinoma stem cell lines. Cell 12 (1977) 973-982
120. Terry A., Kilbey A., Vaillant F., Stewart M., Jenkins A., Cameron E., and Neil J.C. Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene 336 (2004) 115-125
121. Tracey Jr. W.D., Pepling M.E., Horb M.E., Thomsen G.H., and Gergen J.P. A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood. Development 125 (1998) 1371-1380
122. van Wijnen A.J., Stein G.S., Gergen J.P., Groner Y., Hiebert S.W., Ito Y., Liu P., Neil J.C., Ohki M., and Speck N. Nomenclature for Runt-related (RUNX) proteins. Oncogene 23 (2004) 4209-4210
123. Vasseur M., Kress C., Montreau N., and Blangy D. Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 77 (1980) 1068-1072
124. Vasseur M., Katinka M., Herbomel P., Yaniv M., and Blangy D. Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines. J. Virol. 43 (1982) 800-808
125. Velcich A., and Ziff E. Adenovirus E1a proteins repress transcription from the SV40 early promoter. Cell 40 (1985) 705-716
126. Veldman G.M., Lupton S., and Kamen R. Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression. Mol. Cell. Biol. 5 (1985) 649-658
127. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., and Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93 (1996) 3444-3449
128. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bories J.C., Alt F.W., Ryan G., Liu P.P., and Wynshaw-Boris A. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87 (1996) 697-708
129. Wang S., Wang Q., Crute B.E., Melnikova I.N., Keller S.R., and Speck N.A. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13 (1993) 3324-3339
130. Wang S.W., and Speck N.A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12 (1992) 89-102
131. Wasylyk B., Imler J.L., Chatton B., Schatz C., and Wasylyk C. Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types. Proc. Natl. Acad. Sci. USA 85 (1988) 7952-7956
132. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., and Stehelin D. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346 (1990) 191-193
133. Wasylyk C., Imler J.L., Perez-Mutul J., and Wasylyk B. The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Cell 48 (1987) 525-534
134. Weiher H., Konig M., and Gruss P. Multiple point mutations affecting the simian virus 40 enhancer. Science 219 (1983) 626-631
135. Wijmenga C., Speck N.A., Dracopoli N.C., Hofker M.H., Liu P., and Collins F.S. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics 26 (1995) 611-614
136. Woolf E., Xiao C., Fainaru O., Lotem J., Rosen D., Negreanu V., Bernstein Y., Goldenberg D., Brenner O., Berke G., Levanon D., and Groner Y. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100 (2003) 7731-7736
137. Yamaguchi Y., Satake M., and Ito Y. Two overlapping sequence motifs within the polyomavirus enhancer are independently the targets of stimulation by both the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the Ha-ras oncogene. J. Virol. 63 (1989) 1040-1048
138. Yamaguchi-Iwai Y., Satake M., Murakami Y., Sakai M., Muramatsu M., and Ito Y. Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes. Proc. Natl. Acad. Sci. USA 87 (1990) 8670-8674
139. Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A.H., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., and Zhang D.E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15 (1997) 303-306
140. Yokomizo T., Ogawa M., Osato M., Kanno T., Yoshida H., Fujimoto T., Fraser S., Nishikawa S., Okada H., Satake M., Noda T., Nishikawa S., et al. Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells 6 (2001) 13-23
141. Zeng C., van Wijnen A.J., Stein J.L., Meyers S., Sun W., Shopland L., Lawrence J.B., Penman S., Lian J.B., Stein G.S., and Hiebert S.W. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94 (1997) 6746-6751
142. Zhong J., Pevny L., and Snider W.D. "Runx"ing towards sensory differentiation. Neuron 49 (2006) 325-327